Literature DB >> 9366309

Effect of long-term oral L-arginine on the nitric oxide synthase pathway in the urine from patients with interstitial cystitis.

M A Wheeler1, S D Smith, N Saito, H E Foster, R M Weiss.   

Abstract

PURPOSE: We attempted to determine whether oral L-arginine, the substrate for nitric oxide synthase, increases nitric oxide synthase activity and cyclic guanosine monophosphate (cGMP) levels in the urine from interstitial cystitis patients. Nitric oxide and cGMP are decreased in urine from interstitial cystitis patients and both induce smooth muscle relaxation and immunological responses. Increasing urinary nitric oxide and cGMP may ameliorate interstitial cystitis symptoms.
MATERIALS AND METHODS: Eight patients with interstitial cystitis were given L-arginine (1,500 mg. a day) orally for 6 months. Before and during treatment nitric oxide synthase activity and inducible nitric oxide synthase protein, cGMP, nitrate plus nitrite and interleukin 8 (IL-8) levels were measured in urine.
RESULTS: After 2 weeks to 1 month of oral L-arginine treatment, urinary levels of nitric oxide synthase related enzymes and products increased significantly, while levels of the cytokine IL-8 were not changed significantly. IL-8 was significantly elevated in interstitial cystitis patients with leukocyte esterase positive urine.
CONCLUSIONS: Long-term oral administration of L-arginine increases nitric oxide related enzymes and metabolites in the urine of patients with interstitial cystitis, which is associated with a decrease in interstitial cystitis related symptoms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366309     DOI: 10.1016/s0022-5347(01)68150-3

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Interstitial cystitis: new development and a proposal for the IUGA. International Urogynecological Association.

Authors:  J S Gibson
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

2.  Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression.

Authors:  J Jankowski; M van der Giet; V Jankowski; S Schmidt; M Hemeier; B Mahn; G Giebing; M Tolle; H Luftmann; H Schluter; W Zidek; M Tepel
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

3.  Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG).

Authors:  Susan Keay; Jay E Reeder; Kristopher Koch; Chen-Ou Zhang; Daivd Grkovic; Kenneth Peters; Yawei Zhang; John W Kusek; Lee M Nyberg; Christopher K Payne; Kathleen J Propert
Journal:  World J Urol       Date:  2007-08-13       Impact factor: 4.226

4.  Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury.

Authors:  Christopher P Smith; David A Gangitano; Alvaro Munoz; Nilson A Salas; Timothy B Boone; K Roger Aoki; Joseph Francis; George T Somogyi
Journal:  Neurochem Int       Date:  2007-11-26       Impact factor: 3.921

Review 5.  The Chinese approach to complementary and alternative medicine treatment for interstitial cystitis/bladder pain syndrome.

Authors:  Ran Pang; Abdullah Ali
Journal:  Transl Androl Urol       Date:  2015-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.